Association between asymmetric dimethylarginine level and central obesity among patients with acute myocardial infarction: exploratory cross-sectional study
Ihab A Naser, Ammar MA AbuSaada, Riad K Al Qedra · 2026
Read Association between asymmetric dimethylarginine level and central obesity among patients with acute myocardial infarction: exploratory cross-sectional study by Ihab A Naser, Ammar MA AbuSaada, Riad K Al Qedra (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13563731.txt.
Description
Ihab A. Naser and two colleagues ask whether belly fat in heart attack patients comes with higher levels of a molecule that chokes a protective vessel enzyme. The molecule, ADMA, blocks the enzyme that makes nitric oxide, the vessel wall's relaxing signal. Their 2026 cross-sectional study enrolled 120 patients with confirmed heart attacks, aged 30 to 65, at four government hospitals in the Gaza Strip during 2023. Waist size, body mass, blood fats, ADMA, and homocysteine were all measured, and 53.3 percent of patients met the waist cutoff for central obesity.
The centrally obese group carried clearly more ADMA, by 35.1 nanograms per millilitre, and more homocysteine, by 7.7 units, alongside worse cholesterol patterns. In the full regression, waist circumference was the only independent predictor of ADMA levels. The authors label the work exploratory: a single snapshot cannot prove that belly fat raises the molecule, so they call for studies that follow patients forward in time.
Catalog record
| CREATOR | Ihab A Naser, Ammar MA AbuSaada, Riad K Al Qedra |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29753 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |